← All CPOA Flashcard Decks

Ocular Pharmacology Flashcards

7 cards from real CPOA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Ocular Pharmacology flashcards as text
  1. Which ophthalmic agent is contraindicated in patients with a known sulfa drug allergy?

    Answer: Dorzolamide

    Dorzolamide is a carbonic anhydrase inhibitor with a sulfonamide chemical structure, making it contraindicated in patients with sulfa allergies.

  2. A patient using brimonidine (Alphagan) should be monitored for which systemic side effect, especially in infants and young children?

    Answer: CNS depression and apnea

    Brimonidine, an alpha-2 agonist, can cross the blood-brain barrier in young children, causing CNS depression, somnolence, and potentially apnea.

  3. Which mydriatic agent also produces cycloplegia (loss of accommodation)?

    Answer: Cyclopentolate 1%

    Cyclopentolate is an anticholinergic that blocks muscarinic receptors in both the iris sphincter (causing mydriasis) and the ciliary muscle (causing cycloplegia).

  4. What is the duration of action of tropicamide 1% for mydriasis?

    Answer: 4-6 hours

    Tropicamide 1% produces mydriasis lasting approximately 4-6 hours, making it one of the shorter-acting anticholinergic mydriatics.

  5. Fluorescein sodium strips should be moistened with which solution before use?

    Answer: Sterile saline or sterile water

    Fluorescein strips should be moistened with sterile saline or sterile water to prevent contamination and ensure patient safety.

  6. Which glaucoma medication works by increasing uveoscleral (alternative) outflow of aqueous humor?

    Answer: Latanoprost

    Prostaglandin analogs like latanoprost remodel the ciliary muscle extracellular matrix, increasing uveoscleral outflow of aqueous humor.

  7. An antibiotic eye drop prescribed for bacterial conjunctivitis belongs to which drug category when it ends in '-floxacin'?

    Answer: Fluoroquinolone

    The '-floxacin' suffix indicates a fluoroquinolone antibiotic (e.g., ciprofloxacin, moxifloxacin), which work by inhibiting bacterial DNA gyrase and topoisomerase IV.